SCHEMBL22112502

SCHEMBL22112502

C=C1CCC(c2cccc(Cl)c2)(N(C)C)CC1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 6/20 0.47
SLC6A4 P31645 5/20 0.47
SLC6A2 P23975 4/20 0.47
OPRL1 P41146 8/20 0.43
OPRM1 P35372 6/20 0.43
OPRK1 P41145 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CHRNA1 P02708 2/20 0.37
CHRNG P07510 2/20 0.37
CHRNB1 P11230 2/20 0.37
CHRNB2 P17787 2/20 0.37
CHRNB4 P30926 2/20 0.37
CHRNA3 P32297 2/20 0.37
CHRNA4 P43681 2/20 0.37
CHRND Q07001 2/20 0.37
DPP4 P27487 1/20 0.37
CCR2 P41597 1/20 0.36
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11095398 0.84 SLC6A3 (0.47) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL22112324 0.81 SLC6A4 (0.62) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL22112097 0.81 OPRM1 (0.49) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL3407429 0.79 OPRL1 (0.69) OPRL1OPRM1OPRK1
SCHEMBL21780752 0.70 SLC6A3 (0.43) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL22112042 0.69 OPRM1 (0.44) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL19094002 0.69 OPRL1 (0.48) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL19094000 0.69 OPRL1 (0.48) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL28670092 0.69 SLC6A4 (0.48) SLC6A3SLC6A4SLC6A2OPRL1OPRM1
SCHEMBL19120357 0.68 SLC6A3 (0.43) SLC6A3SLC6A4SLC6A2OPRL1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020120539-A1 NEW PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-06-18 WO disclosed